Marine triglyceride and Pollakiuria - a phase IV clinical study of FDA data

Summary:

Pollakiuria is reported as a side effect among people who take Marine triglyceride (fish oil), especially for people who are female, 60+ old, also take Fosamax, and have Osteopenia.

The phase IV clinical study analyzes which people have Pollakiuria when taking Marine triglyceride. It is created by eHealthMe based on reports of 1,937 people who have side effects when taking Marine triglyceride from the FDA, and is updated regularly.

What is Marine triglyceride?

Marine triglyceride has active ingredients of fish oil. eHealthMe is studying from 1,950 Marine triglyceride users. Check the latest studies of Marine triglyceride.

What is Pollakiuria?

Pollakiuria (abnormally frequent passage of relatively small quantities or urine) is found to be associated with 1,749 drugs and 1,692 conditions by eHealthMe. Check the latest studies of Pollakiuria.

On Jul, 04, 2026

1,937 people reported to have side effects when taking Marine triglyceride.
Among them, 29 people (1.5%) have Pollakiuria.

Could Marine triglyceride cause Pollakiuria?

Among these 29 people:

What is the gender of people who have Pollakiuria when taking Marine triglyceride? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Pollakiuria when taking Marine triglyceride? *

What are other drugs people take besides Marine triglyceride? *

What are other side effects people have besides Pollakiuria? *

Femur Fracture: 19 people, 65.52%
Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 14 people, 48.28%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 48.28%
Drug Ineffective: 12 people, 41.38%
Urinary Tract Infection: 12 people, 41.38%
Depression: 11 people, 37.93%
Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 34.48%
Muscle Spasms (muscle contraction): 8 people, 27.59%
Fracture Nonunion (permanent failure of healing following a broken bone): 8 people, 27.59%
Pain In Extremity: 8 people, 27.59%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 15 people, 51.72%
Osteopenia (a condition where bone mineral density is lower than normal): 15 people, 51.72%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 17.24%
High Blood Pressure: 5 people, 17.24%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 10.34%
High Blood Cholesterol: 3 people, 10.34%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.34%
Asthma: 2 people, 6.90%
Depression: 2 people, 6.90%
Hypersensitivity: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Marine triglyceride and have Pollakiuria?

- Check whether Pollakiuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Marine triglyceride:

Marine triglyceride (1,950 reports)

Pollakiuria treatments and more:

Pollakiuria (53,752 reports)

Browse all side effects of Marine triglyceride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pollakiuria:

Pollakiuria (1,749 drugs)

Browse all the conditions that are associated with Pollakiuria:

Pollakiuria (1,692 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fish oil (the active ingredients of Marine triglyceride) and Marine triglyceride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.